Dow Up 0.00% Nasdaq Up 0.09%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
9.68 Down 0.21(2.12%) Nov 28, 1:00PM EST
Prev Close:9.89
Open:9.93
Bid:6.93 x 100
Ask:N/A
1y Target Est:21.00
Beta:4.94
Next Earnings Date:N/A
Day's Range:9.65 - 10.07
52wk Range:7.48 - 15.80
Volume:561,234
Avg Vol (3m):1,119,330
Market Cap:586.52M
P/E (ttm):N/A
EPS (ttm):-0.81
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for INO

Comparison

Symbol% ChgMkt Cap
INODown 2.12%586.52M
AZNUp 0.35%93.68B
PFEUp 0.16%196.27B
SNYUp 0.42%126.72B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):61.53
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.61
Quarterly EPS Est (Dec-14) :-0.13
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback